HD Hyundai Teams Up with Google Cloud to Accelerate AI Innovation
The collaboration will introduce generative AI across Hyundai's core businesses, including its world-leading shipbuilding and top-ranking construction machinery businesses in
Starting in
- Building AI solutions tailored to each industry's needs
- Creating AI-based platforms to enhance customer digital experiences
- Training AI experts
HD Hyundai has already piloted a Generative AI service for after-sales calls at its construction equipment division. The collaboration with Google Cloud commenced in
Earlier moves to boost AI capabilities in-house include:
- Launching an AI Center to develop custom generative AI
- Partnering with POSCO on smart unmanned technology
- Collaborating with Siemens on AI for smart shipyards
HD Hyundai says, "Combining the vast data we have accumulated over the years with Google Cloud's generative AI technology will create great synergy. We will actively utilize AI to improve work efficiency and enhance customer satisfaction."
Underscoring the importance of this collaboration,
About HD Hyundai
HD Hyundai (former Hyundai Heavy Industries Group) is a major South Korean conglomerate that serves as the world's largest shipbuilding and heavy industries manufacturer. Its three core businesses are shipbuilding, heavy equipment, and energy. Shifting towards a holding company structure in
Media Contact
Haeri Na
Manager
HD Hyundai
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/hd-hyundai-teams-up-with-google-cloud-to-accelerate-ai-innovation-302022213.html
SOURCE HD Hyundai
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TORM plc capital increase in connection with exercise of Restricted Share Units as part of TORM's incentive program
- Deepening Trade in Services, Unleashing Cooperation Potential: Norway Guest of Honor Event at CIFTIS Boosts Business Cooperation
- Resolution Therapeutics completes enrollment in Phase I/II EMERALD clinical trial evaluating RTX001 in end-stage liver disease
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share